Lina_S

About Lina Silva Salinas

This author has not yet filled in any details.
So far Lina Silva Salinas has created 418 blog entries.

SIOG and CACA sign Memorandum of Understanding to advance global collaboration in geriatric oncology

2026-05-27T13:40:31+02:00

Geneva/Tianjin 19 May 2026 - The International Society of Geriatric Oncology (SIOG) and the China Anti-Cancer Association (CACA) have signed a Memorandum of Understanding (MoU) establishing a framework for cooperation in oncology care for older adults. The agreement aims to strengthen coordination, promote education, enhance scientific exchange, and support the global development of geriatric oncology. Through this partnership, SIOG and CACA will collaborate on academic activities, international congresses, expert engagement, scientific programs, and publication opportunities. Key areas of cooperation include the mutual promotion of major events, co-hosted webinars, summits, symposia and workshops – such as the recently concluded CACA-SIOG Virtual Summit 2026 in April 30 and a planned CACA-SIOG Symposium during the 2026 China Congress of Holistic Integrative Oncology in Changsha, Hunan Province, PRC. The MoU also encourages manuscript submissions by SIOG experts to the Holistic Integrative Oncology Journal and explores opportunities for qualified SIOG experts to join the journal’s [...]

SIOG and CACA sign Memorandum of Understanding to advance global collaboration in geriatric oncology2026-05-27T13:40:31+02:00

YSIOG member spotlight – February 2026

2026-02-27T15:31:55+01:00

Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.

YSIOG member spotlight – February 20262026-02-27T15:31:55+01:00

YSIOG member spotlight January 2026

2026-01-26T12:12:53+01:00

Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.

YSIOG member spotlight January 20262026-01-26T12:12:53+01:00

YSIOG member spotlight September 2025

2025-08-27T15:31:07+02:00

Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.

YSIOG member spotlight September 20252025-08-27T15:31:07+02:00

YSIOG member spotlight Q2 2025

2025-06-05T15:09:39+02:00

Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.

YSIOG member spotlight Q2 20252025-06-05T15:09:39+02:00
Go to Top